Clinical Research Directory
Browse clinical research sites, groups, and studies.
Transnasal Sphenopalatine Ganglion Block for Postoperative Pain and Recovery in Tonsillectomy (TONwoPA)
Sponsor: Ankara University
Summary
The aim of this clinical trial is to evaluate the effectiveness of transnasal transmucosal sphenopalatine ganglion block in reducing post-tonsillectomy pain. The study also investigates its impact on rescue analgesic requirements and postoperative recovery by comparing 5% lidocaine with placebo. Participants will receive a transnasal transmucosal sphenopalatine ganglion block with either 5% lidocaine or placebo (saline). Postoperative pain levels and opioid consumption will be monitored during the first 24 hours after surgery. In addition, length of hospital stay, the occurrence of primary and secondary post-tonsillectomy hemorrhage up to 14 days, unplanned hospital readmissions after discharge, and patient satisfaction on postoperative day 14 will be assessed.
Official title: Impact of Transnasal Sphenopalatine Ganglion Block on Pain Relief and Recovery Following Tonsillectomy
Key Details
Gender
All
Age Range
12 Years - Any
Study Type
INTERVENTIONAL
Enrollment
28
Start Date
2025-06-01
Completion Date
2026-06-15
Last Updated
2026-01-27
Healthy Volunteers
No
Conditions
Interventions
Transnasal Transmucosal Sphenopalatine Ganglion Block
Before the start of surgery, a preemptive transnasal transmucosal sphenopalatine ganglion block will be performed using cotton-tipped applicators. The assigned solutions will be administered via the applicators according to group allocation.
Lidocaine %5
Transnasal Transmucosal Sphenopalatine Ganglion Block with Lidocaine %5
Saline (0.9% NaCl)
Transnasal Transmucosal Sphenopalatine Ganglion Block with Saline (0.9% NaCl)
Locations (1)
Ankara University
Ankara, Ankara, Turkey (Türkiye)